“The compound SR-17018 is the first biased agonist of the mu opioid receptor that doesn't lead to tolerance with Continual use,” claims Stahl, a senior personnel scientist while in the Bohn lab. “It is a desirable feature for opportunity use from the context of Serious, critical suffering.” – Compared with most opioids, SR-17018 ha